AATB provides hypothesis-driven grants to support research aimed at addressing scientific inquiries related to the use of allograft tissues. As a trade organization representing the industry, eligible grant proposals should emphasize non-proprietary aspects of tissue banking processes, practices, allograft usage, or clinical outcomes pertaining to various categories of allografts.
DECEMBER 1, 2023: LETTER OF INTENT DUE
FEBRUARY 1, 2024: FULL PROPOSAL DUE (FOR APPROVED LOI)
Grant proposals may encompass the following areas:
- Tissue recovery methods, optimization, standards
- Allograft manufacturing/processing methods, optimization, standards
- Clinical efficacy of allograft
- Economic analyses
- Efficiencies of using allograft
- Efficacy of allograft vs. non-allograft technologies
- Other study topics related to allograft utilization
Applicants: Qualified applicants must be from academic research institutions, academic medical centers, or the allograft tissue industry.
Duration: The grant duration is anticipated to be up to 12 months.
Budget: The total budget, encompassing both direct and indirect costs, is capped at $100,000.
Submission & Acceptance
To apply for the grant, candidates are required to submit a Letter of Intent. Submitted Letters of Intent will be reviewed by the AATB’s Scientific and Technical Affairs Committee (STAC). If the Letter of Intent is approved, the applicant will be invited to submit a complete proposal. This full proposal will undergo review by the STAC and final approval by the AATB Board of Governors. Funding will be provided contingent upon the execution of a project contract.
If you have any further questions regarding the AATB Grant Program, please feel free to reach out to us at firstname.lastname@example.org.